For context, 10-15% of the general population tests positive for SIBO or IMO
Fix: Track everything for one week in MyFitnessPal
Nutritional counseling and behavioral support enhance the benefits of pharmacotherapy
Can GLP-1 Weight Loss Drugs Help Treat Menopause-Related Weight Gain
Learn how utilizing health coaching skills in your practice is crucial to your success, leaving a lasting impact on your clients, and shifting the paradigm of womens healthcare
Most Common Uses Retatrutide, an investigational peptide, is gaining attention for its potential in treating metabolic disorders through its innovative triple-agonist mechanism, which simultaneously targets glucagon, glucose-dependent insulinotropic polypeptide (GIP), and glucagon-like peptide-1 (GLP-1) receptors